Soleus Capital Management, L.P. Vaxcyte, Inc. Transaction History

Soleus Capital Management, L.P.

$1.18 Billion
Q3 2024

A detailed history of Soleus Capital Management, L.P. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 27,050 shares of PCVX stock, worth $2.34 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

27,050

Previous 185,250 85.4%

Holding current value

$2.34 Million

Previous $14 Million 77.92%

% of portfolio

0.26%

Previous 1.42%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$70.52 - $117.12 $11.2 Million - $18.5 Million	-158,200 Reduced 85.4%	27,050 $3.09 Million
Q2 2024 Aug 14, 2024	SELL	$60.06 - $78.77 $1.35 Million - $1.77 Million	-22,500 Reduced 10.83%	185,250 $14 Million
Q1 2024 May 15, 2024	SELL	$59.79 - $81.05 $12.4 Million - $16.8 Million	-207,700 Reduced 49.99%	207,750 $14.2 Million
Q4 2023 Feb 14, 2024	SELL	$45.35 - $63.41 $3.82 Million - $5.34 Million	-84,200 Reduced 16.85%	415,450 $26.1 Million
Q3 2023 Nov 14, 2023	SELL	$46.0 - $53.1 $3.29 Million - $3.8 Million	-71,600 Reduced 12.53%	499,650 $25.5 Million
Q2 2023 Aug 14, 2023	BUY	$34.66 - $54.07 $6.62 Million - $10.3 Million	191,000 Added 50.23%	571,250 $28.5 Million
Q1 2023 May 15, 2023	SELL	$36.27 - $47.2 $279,279 - $363,440	-7,700 Reduced 1.98%	380,250 $14.3 Million
Q4 2022 Feb 14, 2023	BUY	$20.58 - $47.95 $1.08 Million - $2.51 Million	52,300 Added 15.58%	387,950 $18.6 Million
Q3 2022 Nov 14, 2022	SELL	$21.69 - $28.53 $759,150 - $998,550	-35,000 Reduced 9.44%	335,650 $8.06 Million
Q2 2022 Aug 15, 2022	BUY	$17.68 - $26.58 $747,864 - $1.12 Million	42,300 Added 12.88%	370,650 $8.07 Million
Q1 2022 May 16, 2022	BUY	$17.46 - $26.36 $586,656 - $885,696	33,600 Added 11.4%	328,350 $7.93 Million
Q4 2021 Feb 14, 2022	SELL	$19.32 - $26.45 $1.18 Million - $1.61 Million	-60,900 Reduced 17.12%	294,750 $7.01 Million
Q3 2021 Nov 15, 2021	SELL	$20.26 - $26.97 $405,200 - $539,400	-20,000 Reduced 5.32%	355,650 $9.02 Million
Q2 2021 Aug 16, 2021	BUY	$16.45 - $24.06 $1.35 Million - $1.97 Million	82,000 Added 27.92%	375,650 $8.46 Million
Q1 2021 May 17, 2021	BUY	$18.66 - $29.16 $5.48 Million - $8.56 Million	293,650 New	293,650 $5.8 Million

Others Institutions Holding PCVX

# of Institutions

353

Shares Held

122M

Call Options Held

775K

Put Options Held

433K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.13B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.

Account

Soleus Capital Management, L.P. Vaxcyte, Inc. Transaction History